Loading…
Aura Biosciences, Inc. is projected to rise to $7.70 by 2027, a +13% move from its current price of $6.84. AURA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $6.60 | $6.84 | $7.09 | +0.02% |
| Jul 13 | $6.51 | $6.84 | $7.19 | +0.04% |
| Jul 14 | $6.44 | $6.84 | $7.28 | +0.06% |
| Jul 15 | $6.38 | $6.85 | $7.35 | +0.08% |
| Jul 16 | $6.33 | $6.85 | $7.41 | +0.11% |
| Jul 17 | $6.28 | $6.85 | $7.47 | +0.13% |
| Jul 18 | $6.24 | $6.85 | $7.52 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.24 | $6.85 | $7.52 | +0.15% |
| Week 2 | $6.01 | $6.86 | $7.83 | +0.30% |
| Week 3 | $5.84 | $6.87 | $8.08 | +0.45% |
| Week 4 | $5.70 | $6.88 | $8.30 | +0.60% |
| Week 5 | $5.59 | $6.89 | $8.50 | +0.75% |
| Week 6 | $5.49 | $6.90 | $8.68 | +0.90% |
| Week 7 | $5.39 | $6.91 | $8.86 | +1.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aura Biosciences, Inc. is a clinical-stage biotechnology company that develops precision therapies to treat solid tumors. Its lead candidate bel-sar is in late-stage clinical development for the treatment of primary choroidal melanoma and other ocular oncology indications, and it is in early-stage clinical development in bladder cancer.
The company focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. Aura Biosciences was incorporated in 2009. It is headquartered in Boston, Massachusetts.
Aura Biosciences, Inc. (AURA) trades at $7.09 per share. Its market capitalization is $733.36M, and it ranks 2744. The current price action sits within a context of a neutral-to-bullish long-range forecast. For 2026, the average price is forecast to be $7.09 with a min of $4.97 and a max of $8.94, yielding a neutral sentiment.
A major floor 22.8% below — a decisive break under it would weaken the trend.
The nearest floor, 10.5% below — buyers have tended to step in here.
The nearest ceiling, 13.2% above — a clean break opens room to run.
A major ceiling 30.1% above — clearing it would confirm fresh momentum.
Key AURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.04 | Sell | $7.01 | Sell |
| MA 10 | $7.07 | Sell | $7.01 | Sell |
| MA 20 | $6.83 | Buy | $6.97 | Sell |
| MA 50 | $7.21 | Sell | $6.97 | Sell |
| MA 100 | $6.80 | Buy | $6.81 | Buy |
| MA 200 | $6.30 | Buy | $6.63 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.86 | Neutral |
| Stoch RSI (14) | 7.97 | Buy |
| CCI (20) | 2.95 | Neutral |
| Williams %R (14) | -89.11 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -2.56 | Sell |
| Bollinger %B (20,2) | 0.51 | Neutral |
| Stochastic %K (14) | 10.89 | Buy |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | 0.12 | Buy |
| Ultimate (7,14,28) | 48.27 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 7.02 | Sell |
| ADX (14) | 12.82 | Neutral |
| ATR (14) | 0.24 | Info |
The 30-day technical picture shows bullish sentiment, with RSI(14) at 50. The stock trades above the SMA200 of $6.28 and near the SMA50 of $7.22, indicating a constructive near-term trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.97 | $6.84 | $8.52 | 0% | Neutral | |
| $5.96 | $7.70 | $10.61 | +13% | Neutral | |
| $7.19 | $9.64 | $13.92 | +41% | Bullish | |
| $8.53 | $11.80 | $17.67 | +73% | Bullish | |
| $8.54 | $12.15 | $18.74 | +78% | Bullish | |
| $8.48 | $12.38 | $19.60 | +81% | Bullish | |
| $8.82 | $13.19 | $21.36 | +93% | Bullish | |
| $8.98 | $13.73 | $22.70 | +101% | Bullish | |
| $10.47 | $16.35 | $27.56 | +139% | Bullish | |
| $12.05 | $19.22 | $32.98 | +181% | Bullish | |
| $14.54 | $25.54 | $47.17 | +273% | Bullish | |
| $24.71 | $51.56 | $105.87 | +654% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.97 | $6.84 | $8.29 | +0.00% |
| August 2026 | $5.71 | $6.79 | $8.34 | -0.71% |
| September 2026 | $5.81 | $6.97 | $8.69 | +2.69% |
| October 2026 | $5.91 | $7.16 | $9.02 | +2.67% |
| November 2026 | $5.65 | $6.88 | $8.76 | -3.88% |
| December 2026 | $5.41 | $6.63 | $8.52 | -3.67% |
Click any year to see its month-by-month AURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AURA could reach as high as $8.52, with a base case around $6.84 and support toward $4.97 — roughly 0% from $6.84. Price action looks broadly range-bound.
Expect AURA to range from $5.96 to $10.61 through 2027. The $7.70 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. A consolidation phase looks the most probable path here.
The AURA price prediction for 2028 points to an average of $9.64 (low $7.19, high $13.92) — a potential gain of +41% on today's $6.84. Momentum favours further upside here.
In 2029, AURA is projected to trade between $8.53 and $17.67, averaging $11.80 — a potential gain of +73% from today's $6.84. That is up +22% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Aura Biosciences, Inc.'s 2030 outlook centres on $12.15, within a $8.54 to $18.74 range. That is up +3% on the projected 2029 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2031, AURA could reach as high as $19.60, with a base case around $12.38 and support toward $8.48 — roughly +81% from $6.84. Buyers look set to stay in control over this stretch.
Expect AURA to range from $8.82 to $21.36 through 2032. The $13.19 average target implies a +93% move from current prices. That is up +6% on the projected 2031 average. Momentum favours further upside here.
The AURA price prediction for 2033 points to an average of $13.73 (low $8.98, high $22.70) — a potential gain of +101% on today's $6.84. Buyers look set to stay in control over this stretch.
In 2034, AURA is projected to trade between $10.47 and $27.56, averaging $16.35 — a potential gain of +139% from today's $6.84. That is up +19% on the projected 2033 average. Momentum favours further upside here.
Aura Biosciences, Inc.'s 2035 outlook centres on $19.22, within a $12.05 to $32.98 range. That is up +18% on the projected 2034 average. That marks a +181% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, AURA could reach as high as $47.17, with a base case around $25.54 and support toward $14.54 — roughly +273% from $6.84. Momentum favours further upside here.
Expect AURA to range from $24.71 to $105.87 through 2050. The $51.56 average target implies a +654% move from current prices. That is up +102% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in AURA today (≈ 146.19883 AURA) could be worth
$7,538.43
+$6,538.43 (+654%) by 2050 · US Dollar
Based on the average projected AURA price of $51.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AURAwould be worth at today's price.
$1,000 invested in AURA on Jul 10, 2025 (≈ 147.710488 AURA) would be worth
$1,010.34
+$10.34 (+1.0%) today · 1.01× · US Dollar
Based on a AURA entry price of $6.77 vs. today's $6.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.74 | $883.72 | -11.6% |
| 1 month ago | $6.12 | $1,117.65 | +11.8% |
| 3 months ago | $6.8 | $1,005.88 | +0.6% |
| 6 months ago | $5.07 | $1,349.11 | +34.9% |
| 1 year ago | $6.77 | $1,010.34 | +1.0% |
| All time (4.7y) ago | $14.8 | $462.16 | -53.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AURA forecast.
Our base-case forecast reaches $14.00 around 2034.
Implied market cap at $14.00: $1.45B
The multi-year forecast points to a bullish trajectory with rising average prices and meaningful upside. In 2030, the average price is $13.69, with a min of $9.43 and a max of $21.56, and a ROI of 93.1% as the sentiment remains BULLISH. By 2040, the average price is $31.27, the max is $59.56 and the min is $17.02, delivering a ROI of 341.1% with a BULLISH sentiment.
In 2050, the average price is $64.20, the max $136.61 and the min $28.89, for a ROI of 805.4% with a BULLISH sentiment. The forecast also shows progressive years such as 2027 (avg $8.35; min $6.39; max $11.68) and 2028 (avg $10.66; min $7.83; max $15.65), reflecting an upward trajectory. These are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $13.69, a min of $9.43, a max of $21.56, with a ROI of 93.1% and bullish sentiment.
Forecasts show rising averages over time with positive ROIs in multiple years (e.g., 2030 ROI 93.1%, 2040 ROI 341.1%, 2050 ROI 805.4%), but 2026 is neutral and forecasts are estimates, not guarantees.
The 2040 max is $59.56, which is just below $60, with an average of $31.27 and a ROI of 341.1%.
2027 average price is $8.35 (min $6.39, max $11.68). 2028 average price is $10.66 (min $7.83, max $15.65). Both carry bullish sentiment.
Forecasts are estimates and not guarantees; actual results may vary across years and ROIs.
Aura Biosciences, Inc. Community Discussion
0Share your Aura Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.